Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Averted NFATc1 Sumoylation in Alloreactive T Cells Ameliorates Acute GvHD

Musga Qureischi, MSc, Lena Dietz, PhD, Martin Vaeth, PhD, Andreas Beilhack, MD, Friederike Berberich-Siebelt, PD PhD

Blood (2016) 128 (22): 809.

https://doi.org/10.1182/blood.V128.22.809.809

Published: 2016

Journal Articles

Targeting and Depletion of Acute Myeloid Leukemia Blasts By MEN1112, a Novel Humanized Defucosylated Monoclonal Antibodies with Specificity for Bst1/CD157 Antigen

Adriano Venditti, Francesco Buccisano, Luca Maurillo, Maria Ilaria Del Principe, Andrea Coppola, Patrizia Palomba, Anna Aureli, Roberto Arriga, Daniela Bellarosa, Alessandro Bressan, Stefano Manzini, Cecilia Simonelli, Monica Binaschi, Sergio Amadori, Giuseppe Sconocchia

Blood (2014) 124 (21): 2235.

https://doi.org/10.1182/blood.V124.21.2235.2235

Published: 2014

Journal Articles

Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis

Lingyan Wu, Cong Yan, Magdalena Czader, Oded Foreman, Janice S. Blum, Reuben Kapur, Hong Du

Blood (2012) 119 (1): 115–126.

https://doi.org/10.1182/blood-2011-06-363093

Published: 2012

Includes: Supplemental data

Journal Articles

Proteasome Inhibitor Bortezomib Disrupts Tumor Necrosis Factor-Related Apoptosis-Inducing ligand (TRAIL) Expression and Natural Killer (NK) Cell Killing of TRAIL Receptor-Positive Multiple Myeloma Cells

Xiaoli Feng, M.D., Jie Yan, MD., Yibiao Wang, MD., Juleen R. Zierath, Ph.D, Magnus Nordenskjöld, MD., Ph.D, Jan-Inge Henter, MD, PhD, Bengt Fadeel, MD, PhD, Chengyun Zheng, MD, PhD

Blood (2010) 116 (21): 5021.

https://doi.org/10.1182/blood.V116.21.5021.5021

Published: 2010

Journal Articles

ICOS Gene Polymorphisms In B-Cell Chronic Lymphocytic Leukemia In a Polish Population.

Irena Frydecka, Lidia Karabon, Anna Jedynak, Anna Tomkiewicz, Edyta Pawlak, Dariusz Wolowiec, Marek Kielbinski, Kazimierz Kuliczkowski, Dariusz Woszczyk, Tomasz Wrobel, MD, PhD

Blood (2010) 116 (21): 4614.

https://doi.org/10.1182/blood.V116.21.4614.4614

Published: 2010

Journal Articles

Hypercalcemia Following Treatment with Lenalidomide in Chronic Lymphocytic Leukemia (CLL).

Bijal D. Shah, MD, Marays Veliz, MD, Ricardo Santana, Jeffrey E Lancet, MD, John J. Powers, B.S., Jason A Dubovsky, B.S., Sara Tinsley, Darcie Deaver, ANP, MS, Eduardo M. Sotomayor, MD, Javier Pinilla, MD, PhD

Blood (2009) 114 (22): 4413.

https://doi.org/10.1182/blood.V114.22.4413.4413

Published: 2009

Journal Articles

A Mouse Model for Immunotherapeutic Reversal of Leukemia-Induced T Cell Dysfunction

Alan G. Ramsay, PhD, Gullu Gorgun, PhD, Tobias A.W. Holderried, David Zahrieh, MS, Fenglong Liu, PhD, John Quackenbush, PhD, Carlo M. Croce, MD, John G. Gribben, MD, DSc

Blood (2008) 112 (11): 30.

https://doi.org/10.1182/blood.V112.11.30.30

Published: 2008

Journal Articles

Hodgkin Disease and Nephrotic Syndrome, a Rare Paraneoplastic Complication in Children with Literature Review

Sehba Dsilva, MD, Gungor Karayalcin, MD, Sharon Singh, MD

Blood (2008) 112 (11): 4832.

https://doi.org/10.1182/blood.V112.11.4832.4832

Published: 2008

Journal Articles

N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity.

Michael Y. Shapira, MD, Lola Weiss, PhD, Shoshana Reich, Michael Zeira, PhD, Shimon Slavin, MD

Blood (2006) 108 (11): 5171.

https://doi.org/10.1182/blood.V108.11.5171.5171

Published: 2006

Journal Articles

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo.

J. Vera, MD, C. Quintarelli, PhD, B. Savoldo, MD, G. Giordano, PhD, A. Foster, PhD, M. Pule, MD, Helen Heslop, MD, C. Rooney, PhD, Malcolm Brenner, MD, PhD, G. Dotti, MD

Blood (2006) 108 (11): 1721.

https://doi.org/10.1182/blood.V108.11.1721.1721

Published: 2006

Journal Articles

Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines

Lorenza Cannarile, Francesca Fallarino, Massimiliano Agostini, Salvatore Cuzzocrea, Emanuela Mazzon, Carmine Vacca, Tiziana Genovese, Graziella Migliorati, Emira Ayroldi, Carlo Riccardi

Blood (2006) 107 (3): 1039–1047.

https://doi.org/10.1182/blood-2005-05-2183

Published: 2006

Journal Articles

Enhancement of Lymphokine-Activated Killer Cell Cytotoxicity by Mistletoe Plant Extracts.

Georg Seifert, Holger N. Lode, MD, Stephan Lobitz, MD, Karl Seeger, MD, PhD, Alfred Laengler, MD, Guenter Henze, MD

Blood (2005) 106 (11): 3919.

https://doi.org/10.1182/blood.V106.11.3919.3919

Published: 2005

Journal Articles

Trisenox (Arsenic Trioxide) in the Treatment for Multiple Myeloma after Bone Marrow Transplantation.

Benjamin Gesundheit, MD, PhD, Michael Y. Shapira, MD, Igor Resnick, MD, Menachem Bitan, MD, Dina Ben-Yehuda, MD, Shimon Slavin, MD, Reuven Or, MD

Blood (2005) 106 (11): 5128.

https://doi.org/10.1182/blood.V106.11.5128.5128

Published: 2005

Journal Articles

Orphan Granzymes Downstream from Granzyme B Are Important for Tumor Clearance In Vivo and in Vitro .

Xuefang Cao, PhD, Paula A. Revell, PhD, William J. Grossman, MD, PhD, Dori A. Thomas, PhD, Zhi Hong Lu, PhD, Timothy J. Ley, MD

Blood (2004) 104 (11): 2653.

https://doi.org/10.1182/blood.V104.11.2653.2653

Published: 2004

Journal Articles

Cultured Human B Cell APCs Expanded Using Il-4 and CD40 Ligand Preferentially Promote a Type 2 T Cell Response to Alloimmune Stimulation.

Abdul Tawab, Ph.D., Yoshiyuki Takahashi, M.D., Childs Richard, M.D., Kurlander J. Roger, M.D.

Blood (2004) 104 (11): 2668.

https://doi.org/10.1182/blood.V104.11.2668.2668

Published: 2004

Journal Articles

The NK and NKT Cell Compartment Is Suppressed in CML Patients before and after Imatinib Treatment.

Christiane I.-U. Chen, M.D., Holden Maecker, Ph.D., Peter P. Lee, M.D.

Blood (2004) 104 (11): 4667.

https://doi.org/10.1182/blood.V104.11.4667.4667

Published: 2004

Journal Articles

The Addition of Interleukin (IL)-15 to ANTI-CD3, IL-2 and FLT-3 Results in Significant Increase in Expansion, Activation, Proliferation and Survival of Cord Blood (CB) NK Cells and Cytotoxic T-Lymphocyte (CTL) Subsets: Potential for Adoptive Cellular Immunotherapy (ACI).

Prakash Satwani, MD, Allison F. O’Neill, Janet Ayello, MS, Lynn Simpson, MD, Dustin Cairo, Carmella van de Ven, MA, Mitchell S. Cairo, MD

Blood (2004) 104 (11): 4952.

https://doi.org/10.1182/blood.V104.11.4952.4952

Published: 2004

Journal Articles

Endothelial Cell Injury of Carmustine (BCNU) in Hepatic Sinusoids: Contribution of Oxidation and Immune Reaction.

Oner Ozdemir, MD, Yaddanapudi Ravindranath, MD, Sureyya Savasan, MD

Blood (2004) 104 (11): 1154.

https://doi.org/10.1182/blood.V104.11.1154.1154

Published: 2004

Journal Articles

Aerolysin Cytotoxicity Can Serve as a Surrogate Marker for Immune Sensitivity of Tumor Cells to Granule-Exocytosis Pathway in Vitro.

Oner Ozdemir, MD, Mustafa Buyukavci, MD, Yaddanapudi Ravindranath, MD, Sureyya Savasan, MD

Blood (2004) 104 (11): 3864.

https://doi.org/10.1182/blood.V104.11.3864.3864

Published: 2004

Journal Articles

Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness

Christa E. Muller-Sieburg, Rebecca H. Cho, Lars Karlsson, Jing-F. Huang, Hans B. Sieburg

Blood (2004) 103 (11): 4111–4118.

https://doi.org/10.1182/blood-2003-10-3448

Published: 2004

NARROW

Averted NFATc1 Sumoylation in Alloreactive T Cells Ameliorates Acute GvHD

Targeting and Depletion of Acute Myeloid Leukemia Blasts By MEN1112, a Novel Humanized Defucosylated Monoclonal Antibodies with Specificity for Bst1/CD157 Antigen

Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis

Proteasome Inhibitor Bortezomib Disrupts Tumor Necrosis Factor-Related Apoptosis-Inducing ligand (TRAIL) Expression and Natural Killer (NK) Cell Killing of TRAIL Receptor-Positive Multiple Myeloma Cells

ICOS Gene Polymorphisms In B-Cell Chronic Lymphocytic Leukemia In a Polish Population.

Hypercalcemia Following Treatment with Lenalidomide in Chronic Lymphocytic Leukemia (CLL).

A Mouse Model for Immunotherapeutic Reversal of Leukemia-Induced T Cell Dysfunction

Hodgkin Disease and Nephrotic Syndrome, a Rare Paraneoplastic Complication in Children with Literature Review

N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity.

Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo.

Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines

Enhancement of Lymphokine-Activated Killer Cell Cytotoxicity by Mistletoe Plant Extracts.

Trisenox (Arsenic Trioxide) in the Treatment for Multiple Myeloma after Bone Marrow Transplantation.

Orphan Granzymes Downstream from Granzyme B Are Important for Tumor Clearance In Vivo and in Vitro .

Cultured Human B Cell APCs Expanded Using Il-4 and CD40 Ligand Preferentially Promote a Type 2 T Cell Response to Alloimmune Stimulation.

The NK and NKT Cell Compartment Is Suppressed in CML Patients before and after Imatinib Treatment.

The Addition of Interleukin (IL)-15 to ANTI-CD3, IL-2 and FLT-3 Results in Significant Increase in Expansion, Activation, Proliferation and Survival of Cord Blood (CB) NK Cells and Cytotoxic T-Lymphocyte (CTL) Subsets: Potential for Adoptive Cellular Immunotherapy (ACI).

Endothelial Cell Injury of Carmustine (BCNU) in Hepatic Sinusoids: Contribution of Oxidation and Immune Reaction.

Aerolysin Cytotoxicity Can Serve as a Surrogate Marker for Immune Sensitivity of Tumor Cells to Granule-Exocytosis Pathway in Vitro.

Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only